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During bacterial and viral infections, unmethylated
CpG-DNA released by proliferating and dying mi-
crobes is recognized by toll-like receptor (TLR) 9 in
host cells, initiating innate immune responses. Many
corneal infections occur secondary to epithelial
breaches and represent a major cause of vision im-
pairment and blindness globally. To mimic this clin-
ical situation, we investigated mechanisms of TLR9
ligand–induced corneal inflammation in mice after
epithelial debridement. Application of CpG oligode-
oxynucleotides (ODNs) resulted in neutrophil and
macrophage infiltration to the cornea and loss of
transparency. By 6 hours after CpG-ODN administra-
tion, TLR9 mRNA was increased in the cornea and
retina. In vivo clinical examination at 24 hours re-
vealed inflammatory infiltrates in the vitreous and
retina, which were confirmed ex vivo to be neutro-
phils and macrophages, along with activated resident
microglia. CpG-ODN–induced intraocular inflamma-
tion was abrogated in TLR9/ and macrophage-de-
pleted mice. Bone marrow reconstitution of irradi-
ated TLR9/ mice with TLR9/ bone marrow led to
restored corneal inflammatory responses to CpG-
ODN. Fluorescein isothiocyanate–CpG-ODN rapidly
penetrated the cornea and ocular media to reach the
retina, where it was present within CD68 retinal
macrophages and microglia. These data show that
topically applied CpG-ODN induces intraocular in-
flammation owing to TLR9 activation of monocyte-
lineage cells. These novel findings indicate thatmicrobial CpG-DNA released during bacterial and/or
viral keratitis can cause widespread inflammation
within the eye, including the retina. (Am J Pathol 2012,
180:209–220; DOI: 10.1016/j.ajpath.2011.09.041)
Activation of toll-like receptors (TLRs) that recognize dis-
tinct pathogen-associated molecular patterns unique to
bacteria, viruses, fungi, parasites, and some endoge-
nous ligands1 is well recognized as an initiation step in
the inflammatory cascade that follows corneal infec-
tion.2–5 Scarring and opacification of the cornea, second-
ary to various forms of infection, are significant causes of
visual impairment globally.6 A complete picture of the
distribution and phenotype of resident macrophages and
dendritic cells (DCs) in the mouse cornea has emerged in
recent years,7–9 and we have previously shown that they
play a pivotal role in recognition of the TLR4 ligand lipo-
polysaccharide (LPS) and the initiation of local innate
immune responses when the corneal epithelium is
breached.10 In addition, corneal macrophages play a
critical role in corneal allograft rejection11 and in the
recognition and clearance of Pseudomonas aeruginosa
bacteria.12,13
TLR9 recognizes unmethylated CpG-rich motifs that are
found in high abundance in bacterial and viral DNA.14 Rec-
ognition of the TLR9 ligand, bacterial DNA, and its synthetic
homologue [unmethylated CpG oligodeoxynucleotide
(ODN)] occurs intracellularly within endosomal compart-
ments.15 Based on their capacity to activate different
subsets of myeloid cells, CpG-ODNs are classified as
type A, B, or C (C being a combination of types A and
B).16 Type A CpG-ODN strongly activates plasmacy-
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B CpG-ODNs are poor inducers of IFN-/ but strongly
activate B cells and induce transcriptional activation of
NF- in monocytes, macrophages, and DCs, resulting in
tumor necrosis factor- production.17 The mouse corneal
stroma normally lacks B cells but contains rich networks of
resident CD11b F4/80 macrophages and CD11c
CD11b myeloid DCs, along with a small population of
CD11cB220 plasmacytoid DCs.7,8,18,19
Previous studies have demonstrated that TLR9 signaling
plays an important role in the host defense against infec-
tious diseases of the cornea, including Pseudomonas kera-
titis3 and herpes simplex virus (HSV)-1 keratitis.20 Modula-
tion of the corneal inflammatory response to P. aeruginosa,
Staphylococcus aureus, and HSV-1 keratitis has been dem-
onstrated by TLR silencing and the use of TLR knockout
mouse models.3–5,20 After exposure of CpG-ODN to the
debrided corneal epithelium, we know that TLR9 signaling
leads to the production of the chemokines KC and macro-
phage inflammatory protein-2, which recruit neutrophils to
the cornea.21,22 Huang et al23 also revealed that, after
subconjunctival injection of CpG-ODN, there was signif-
icant up-regulation of IL-1, macrophage inflammatory
protein-2, IL-12, and IFN- mRNA in the cornea. It is
unclear whether nonhematopoietic corneal cells (epithe-
lial or stromal keratocytes) and/or resident myeloid cells
mediate the innate immune responses to topically ap-
plied TLR9 ligand5,21 or whether the inflammatory re-
sponse is restricted to the cornea.
In the present study, we demonstrate, for the first time
to our knowledge, that application of CpG-ODN to the
abraded cornea leads to inflammation in the anterior
uveal tract (iris/ciliary body), vitreous, and retina because
of rapid movement of CpG-ODN through the ocular me-
dia to the posterior segment of the eye. We reveal that
this widespread intraocular inflammation is TLR9 depen-
dent and is abrogated in macrophage-depleted Macro-
phage Fas ligand-Induced Apoptosis (Mafia) mice.
These novel data demonstrate a mechanism by which
release of small quantities of bacterial/viral DNA, arising
from ocular surface infections, may quickly diffuse
through the aqueous ocular environment to initiate inflam-
mation of the retina. This phenomenon is also likely to be
relevant in innate immune responses at other sites, such
as the meninges and brain parenchyma, the homologues
of the cornea and retina, respectively.
Materials and Methods
Animals
C57BL/6 and BALB/c mice, aged 6 to 12 weeks, were
sourced from the Animal Resources Centre (Murdoch,
WA, Australia) and Monash Animal Services (Monash
University, Clayton, VIC, Australia). Six-week-old Mafia
mice were obtained from Sandra Burnett (Brigham Young
University, Provo, UT). TLR9/ mice, provided by Dr. S.
Akira (Osaka University, Osaka, Japan), were fully back-
crossed onto a C57BL/6 background. All animal proce-
dures were performed in accordance with the guidelinesof local Animal Ethics Committees at the University of
Western Australia (Perth, WA), Monash University, and
Case Western Reserve University (Cleveland, OH).
Mouse Model of Corneal Inflammation
Mice were anesthetized by i.p. injection of either ket-
amine-xylazine or 2,2,2-tribomoethanol (1.2%; Sigma-
Aldrich, St. Louis, MO), and the epithelium of the cen-
tral cornea was debrided using an Algerbrush II corneal
rust ring remover with a 0.5-mm burr (Alger Equipment
Co, Lago Vista, TX), as previously described.21 Immedi-
ately after epithelial debridement, 20 g of phosphoro-
thioate CpG 1826 (type B) oligonucleotide (5=-TCC-
ATGACGTTCCTGACGTT-3=), control oligonucleotide
1826 (control ODN=; 5=-TCCATGAGCTTCCTGAGCTT-
3=), CpG 1585 (type A; 5=-GGGGTCAACGTTGAGGGGG-3=),
or 20 g of Ultra Pure Escherichia coli LPS (strain K12; Invitro-
gen, San Diego, CA) was applied to each eye. For analysis of
ocular inflammation, animalswere euthanizedat 30minutes; 2,
6, 24, and 72 hours; and 1 week. To determine whether expo-
sure to CpG-ODN in one eye would be sufficient to induce
inflammation in the contralateral eye, some experiments were
performed whereby the contralateral eye was debrided and
treatedwith controlODN. Furthermore, to examinewhether the
intraocular inflammation could be reproduced by systemic
exposure toCpG-ODN,mice received an i.p. or i.v. injection of
40 g of CpG-ODN and one eye was debrided and treated
with control ODNwhile the contralateral eye was left untreated
(naïve). To localize the movement of CpG-ODN in the eye, 10
g of CpG-ODN 1826 fluorescein isothiocyanate (FITC; Invit-
rogen) was applied to the debrided cornea, and animals were
sacrificed at 4 hours, 24 hours, or 1 week after treatment. The
lower dosage of 10 g was chosen as the level of fluorescent
staining of the cornea using 20 g of CpG-FITC made exam-
ination of the fundus difficult.
Spectral Domain Optical Coherence
Tomography, Scanning Laser Ophthalmoscopy,
and Fluorescein Angiography
Immediately before euthanasia, mice were anesthetized
using ketamine-xylazine and their pupils were dilated
with tropicamide eye drops (Mydriacyl, 0.5%; Alcon Aus-
tralia, Frenchs Forest, Australia). The fundi of eyes of
representative animals were imaged using the combined
scanning-laser ophthalmoscope and spectral domain
optical coherence tomography (OCT) device (Heidelberg
Spectralis-OCT; Heidelberg Engineering, Dossenheim,
Germany). Scanning laser ophthalmoscopy fundus im-
ages of the central mouse retina and vitreous were ac-
quired using a 55-degree lens. For analysis of retinal
vasculature, mice received 50 L of 10% sodium fluores-
cein (Alcon Laboratories, Frenchs Forest, NSW, Austra-
lia) by i.p. injection, and images were captured using the
fluorescein angiography mode. To acquire OCT images
of the mouse retina/vitreous, a 30-degree wide-angle lens
was used. All data were processed using Eye Explorer
Software (Heidelberg Engineering).
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Eyes were enucleated and snap frozen in embedding
medium (optical cutting temperature compound, Tissue-
Tek; Proscitech, Thuringowa, QLD, Australia) using dry
ice. Cryosections (6 m thick) were fixed in 4% parafor-
maldehyde or acetone (for F4/80 staining) and immuno-
stained with rat anti-mouse monoclonal antibody NIMP-
R14 (Abcam, Cambridge, UK), which specifically stains
neutrophils, or with the pan-macrophage marker F4/80
(Serotec, Oxford, UK). Sections were incubated for 45
minutes with Strep Alexa Fluor 594–conjugated anti-rat
IgG (1:200; Molecular Probes, Carlsbad, CA) and for 5
minutes with DAPI (Roche Diagnostics, Mannheim, Ger-
many). Cells were counted in each section by a blinded
observer (SM; from limbus to limbus; original magnifica-
tion, 400) by fluorescence microscopy (Olympus BX60;
Olympus, Tokyo, Japan).
Whole-Mount Immunofluorescence
Corneas and retinas were dissected from eyes that had
been fixed in 4% paraformaldehyde and processed as
whole mounts, as previously described for immunostain-
ing.24 A range of anti-leukocytemonoclonal antibodies were
used, including anti-ionized calcium binding adaptor mole-
cule 1 (Iba-1; Wako Pure Chemical Industries, Osaka, Ja-
pan), anti-major histocompatibility complex (MHC) class II
(BD Pharmingen, San Diego, CA), and anti-neutrophil and
biotinylated Griffonia simplicifolia B4 isolectin (IB4; Vector
Laboratories, Burlingame, CA). After overnight incubation,
tissues were washed with PBS and then incubated with
appropriate secondary and tertiary antibodies [namely,
goat anti-rabbit biotin (Iba-1), goat anti-rat biotin (MHC II
and NIMP), or streptavidin Cy3; Jackson ImmunoResearch,
West Grove, PA]. To visualize nuclei, tissues were incu-
bated in DAPI (Roche Applied Science, Mannheim, Ger-
many) for 10 minutes at room temperature. For negative
controls, either isotype IgG primary antibodies were used or
primary antibodies were omitted altogether. To calculate the
mean number of NIMP and MHC II cells, three random
images were taken from each retinal whole mount using a
20 objective, and immunopositive cells were counted in
the three images and the density was averaged.
Real-Time RT-PCR
Eyes were enucleated at 6 or 24 hours after topical ap-
plication of either control ODN or CpG-ODN, immediately
placed into RNAlater (Qiagen GmbH, Hilden, Germany),
and stored at 4°C overnight. Total RNA was extracted
from corneal and retinal tissue using the RNeasy Mini
Kit (Qiagen), following the manufacturer’s instructions.
cDNA was prepared from 800 ng of total RNA for exper-
imental samples (retina and cornea at 6 and 24 hours)
and 2 g of total RNA for standard curve samples (spleen
tissue, High Capacity cDNA-to-RNA Kit; Applied Biosys-
tems Inc., Foster City, CA). SYBR Green–based real-time
PCRs were run in triplicate (Fast SYBR Green Master Mix;
Applied Biosystems) on the Rotor-Gene 3000 (Corbett
Research/Qiagen). Ribosomal protein L32 (forward, 5=-TTAAGCGAAACTGGCGGAAAC-3=; reverse, 5=-TTGTT-
GCTCCCATAACCGATG-3=) was used as the house-
keeping gene. Expression levels of TLR9 (forward, 5=-
AGGCTGTCAATGGCTCTCAGTT-3=; reverse, 5=-TGAA-
CGATTTCCAGTGGTACAAGT-3=) and IFN- (forward,
5=-AGCAACAGCAAGGCGAAAA-3=; reverse, 5=-CTG-
GACCTGTGGGTTGTTGA-3=) were normalized against ri-
bosomal protein L32. Fold changes in expression of TLR9
and IFN- at 6 and 24 hours after CpG-ODN administration,
compared with controls, were determined using 2CT.25
Depletion of CSF-1 Receptor–Expressing Cells
Using Mafia Mice
Burnett and colleagues26 generated transgenic mice de-
signed for inducible macrophage and DC depletion by
Fas-ligand–induced apoptosis. The transgene is under
control of the c-fms promoter that regulates expression of
the colony stimulating factor-1 (CSF-1) receptor ex-
pressed on macrophages and DCs. These mice express
enhanced green fluorescent protein (eGFP) and a mem-
brane-bound suicide protein comprising the human low-
affinity nerve growth factor receptor, the FK506 binding
protein, and the cytoplasmic domain of Fas. AP20187 is
a covalently linked dimer (Ariad Pharmaceuticals, Cam-
bridge, MA) that cross-links the FK506 binding protein
region of the suicide protein and induces caspase 8–de-
pendent apoptosis.26 Mafia mice are on a C57BL/6 back-
ground and have a normal phenotype in the absence of
the dimerizer. To deplete macrophages and DCs,
AP20187 was diluted to 0.55 mg/mL in 4% ethanol, 10%
polyethylene glycol-400, and 1.7% Tween 80 in sterile wa-
ter;Mafiamice were injected i.p. daily for 5 days with 40 g
of the AP20187 dimerizer per injection (total, 200 g) before
corneal application of CpG-ODN. Control Mafia mice re-
ceived injections of sterile saline.
Generation of Bone Marrow Chimeric Mice
Recipient TLR9/ and wild-type (WT) C57BL/6 mice,
aged 6 to 8 weeks, were irradiated with two doses of 5.5
Gy 3 hours apart. The femur and tibia bones were har-
vested from donor mice (Cx3cr1
gfp/), and the shafts
were centrifuged at 4500  g for 30 seconds at 4°C, as
previously described.27 The pellet was resuspended in
RPMI 1640 medium (Sigma Chemical Co, St Louis, MO)
and centrifuged at 250  g for 5 minutes at room tem-
perature, and live cells were counted by trypan blue
exclusion. Recipient mice received an i.v. injection of 5 
106 bone marrow cells (in 150 L of RPMI 1640 medium)
via the lateral tail vein. Antibiotic cover was provided in
drinking water to recipient mice [800 L/L enrofloxacin
(Baytril 25); Bayer Health Care, Pymble, NSW, Australia]
for 10 days after irradiation. Chimeric mice were treated
at 12 weeks after reconstitution (n  4 to 6 per treatment
group).
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eGFP Monocyte Infiltration into the Cornea
Immediately after euthanasia, corneas were examined by
in vivo confocal microscopy (Confoscan 4; Nidek Tech-
nologies, New Orleans, LA). Images were captured every
2 m throughout the thickness of the cornea, and light
intensity (reflectivity) values for each image were cap-
tured using accompanying software (NAVIS; Lucent
Technologies, Murry Hill, NJ) and exported as an Excel
file. Reflectivity values for the corneal stroma were plotted
in relation to distance from the corneal endothelium to the
basal epithelium to generate a curve, and the area under
the curve was calculated using GraphPad Prism software
(GraphPad Software, San Diego, CA). This measurement
was termed stromal haze and is described in arbitrary
units of corneal clarity, as in our previous studies.21,28
Measurements were completed within a few minutes
after euthanasia, and control animals were treated
identically; thus, postmortem corneal edema was min-
imal. To visualize eGFP monocytic cell infiltration in
Mafia mice, corneas were imaged and analyzed using
a high-resolution stereofluorescence MZFLIII micro-
scope (Leica Microsystems, Inc., Bannockburn, IL)
and SpotCam software (RT Slider KE; Diagnostics In-
struments, Sterling Heights, MI).27
In Vivo Examination of CpG-FITC in the
Posterior Segment
For qualitative analysis of CpG-FITC dissemination in the
posterior segment, mouse retinas were imaged using the
Micron III retinal imaging microscope (Phoenix Research
Laboratories, Inc., San Ramon, CA). At 4 hours, 24 hours,
or 1 week after corneal CpG-FITC treatment, anesthe-
tized mice (ketamine-xylazine) received topical Mydriacyl
eye drops (0.5%; Alcon Australia, Frenchs Forest, Aus-
tralia) to dilate pupils. A drop of eye gel (Viscotears;
Novartis Pharmaceuticals Australia Pty Limited, Australia)
was placed on the objective that comes into contact with
the mouse cornea. By using the bright-field and 488
fluorescence filters, images of the mouse retina were
captured with a 3 chip color-device camera.
Statistical Analysis
Mean values for each experiment were compared be-
tween groups using a one-way analysis of variance and
Tukey’s post hoc comparison, with P  0.05 considered
statistically significant.
Results
Type B CpG-ODN Induces Acute Neutrophilic
Infiltration to the Corneal Stroma and a Delayed
Macrophage Response
Our laboratory and others5,21 have shown that activation
of the mouse cornea by the TLR9 ligand CpG-ODN (type
B) causes corneal haze, inflammatory cell infiltration, andproduction of the IFN-–inducible protein CXCL10. The
number of neutrophils infiltrating the corneal stroma
peaked at 24 hours, whereas macrophage numbers con-
tinued to increase 1 week after treatment (Figure 1, A–C).
In contrast, application of a control ODN (CpG-ODN),
which has no TLR9 binding activity, induced attenuated
recruitment of macrophages in the absence of a neutro-
phil response, elicited by the debridement procedure
(Figure 1C). Type A CpG-ODN failed to produce corneal
inflammation; thus, in all subsequent experiments, type B
CpG-ODN was used.
At 6 hours after treatment, when neutrophil and mac-
rophage numbers were low (Figure 1C), TLR9 mRNA
expression was elevated in the CpG-ODN–treated cor-
neas compared with control ODN-treated corneas and
was further elevated at 24 hours (Figure 1D). IFN-mRNA
was elevated 10-fold in the cornea by 6 hours and 200-
fold after 24 hours (Figure 1E). These data demonstrate
that the TLR9 ligand, type B CpG-ODN, is a potent in-
ducer of acute corneal inflammation when applied to the
debrided corneal surface.
TLR9-Dependent CpG-ODN–Induced Keratitis
Is Mediated by Cells of Myeloid Origin
To determine whether resident macrophages and DCs
mediate the initial recognition of TLR9 ligands in the cor-
nea, we used Mafia mice, in which macrophages and
DCs express eGFP constitutively and undergo cell lin-
eage–specific apoptosis after cross-linking the FK506
binding domain of the membrane-bound suicide protein
using the FK506 dimerizer AP20187.26 After depletion of
eGFP macrophages/DCs, AP20187-treated Mafia
mice are unable to respond to LPS10 and Aspergillus
fumigatus.29 In vivo imaging of nondimerized Mafia
mice 24 hours after corneal application of CpG-ODN
demonstrated many eGFP cells infiltrating the corneal
stroma and iris (Figure 2A). In comparison, dimerizer-
treated Mafia mice retained few eGFP cells in the cor-
neal stroma (Figure 2B) and displayed reduced corneal
haze and neutrophil infiltration after CpG-ODN treatment
(Figure 2, C and D). These data clearly demonstrate that
monocytic-lineage cells play a critical role in the innate
immune response triggered by corneal exposure to TLR9
ligand.
To further investigate the contribution of resident cor-
neal macrophages in the generation of inflammatory re-
sponses to topically applied CpG-ODN, TLR9/ mice
were lethally irradiated and given bone marrow from
TLR9/Cx3cr1
gfp/ mice (WT¡TLR9/). Previous
studies30,31 have demonstrated an almost complete re-
plenishment of resident corneal bone-marrow–derived
cells by 12 weeks after transplantation. Thus, at 12 weeks
after transplantation, when resident monocyte-derived
cells are the only TLR9/ cells in the cornea, mice were
challenged with topical CpG-ODN or control ODN; 24
hours later, neutrophil and macrophage infiltration was
quantified (Figure 2, E and F). In TLR9/ mice, the
number of neutrophils and macrophages was equivalent
to control ODN-treated corneas. In WT¡TLR9/ mouse
(C). Up
ata are g
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the number of neutrophils recruited to the cornea com-
pared with CpG-ODN–treated TLR9/ corneas and con-
trol ODN-treated corneas. However, the inflammatory re-
sponse did not reach the levels of inflammation observed
in WT¡WT chimeric mice (Figure 2E). Quantitation of
macrophage infiltration to the cornea revealed a full re-
constitution of the CpG-ODN response in the corneas of
WT¡TLR9/ mice, which was indistinguishable from
WT¡WT mice (Figure 2F).
CpG-ODN–Induced Keratitis Is Accompanied
by Widespread Intraocular Inflammation
In a similar murine model of LPS-induced corneal inflam-
mation, a mild degree of neutrophilic infiltration is ob-
served in the anterior segment compared with control
ODN-treated eyes at 24 hours (Figure 3, A and B). By
contrast, CpG-ODN application to the debrided corneal
surface resulted in a much more widespread and striking
degree of neutrophil and macrophage infiltration, which
involves the entire anterior uveal tract (iris/ciliary body),
anterior chamber, and posterior chamber (Figure 3C). An
examination of the retina and vitreous using in vivo fundus
scanning laser ophthalmoscopy, fluorescein angiogra-
phy, and OCT revealed normal fundus and retinal vascu-
lature in control ODN-treated eyes; however, vitreous
haze and inflammatory infiltrates in the vitreous and retina
were detected in CpG-ODN–treated eyes (Figure 3, D–I).
Figure 1. Inflammatory cell recruitment to the cornea after topically appli
cornea at 24 hours (A) and F4/80 macrophages at 1 week after treatment (
to the cornea after topical application of CpG-ODN or control ODN is shown
CpG-ODN–treated eyes at 6 and 24 hours (n  4 to 10 mice per group). DThere did not appear to be any compromise of the blood-retinal barrier because no leakage was detected via flu-
orescein angiography (Figure 3, E and G).
Retinal whole mounts were immunostained to examine
the phenotype and kinetics of inflammatory cell infiltration
after topically applied CpG-ODN. Adherent intravascular
neutrophils appeared in retinal vessels as early as 6
hours after exposure to the corneal surface with CpG-
ODN (Figure 4A), with peak infiltration at 24 hours (Figure
4B) and resolution by 72 hours (Figure 4C). In the normal
retina, CD45low CD11blow CD68low CX3CR1 Iba-1 and
MHC class II monocyte-derived ramified microglia are
the predominant tissue resident leukocyte population
(Figure 4, D–F).32,33 Hallmarks of microglial activation
include up-regulation of Iba-1 and MHC class II and
changes in morphological appearance, whereby the dis-
tinct fine ramifications are lost and the soma becomes
enlarged, with fewer stouter processes.34 At 24 hours
after corneal CpG-ODN treatment, microglia in the gan-
glion cell layer exhibited enlarged soma and there was a
large influx of Iba-1 round cells (Figure 4, G and H).
There was evidence of continued activation up to 1 week
after treatment (Figure 4I). Rare MHC class II DCs are
localized to the juxtapapillary margin, optic disc region,
and perivascular sites of the normal mouse retina35 (Fig-
ure 4J). After CpG-ODN treatment, many round MHC
class II cells were detected in the inner retina within 24
hours (Figure 4, K and L). By 72 hours, the frequency of
these cells had declined, but they remained present in
significant numbers for at least 1 week after treatment
-ODN. Immunohistochemical staining of NIMP neutrophils in the central
uclei are blue) (B). The kinetics of macrophage and neutrophil recruitment
-regulation of TLR9 mRNA (D) and IFN- mRNA (E) in isolated corneas from
iven as mean  SEM.ed CpG
DAPI ncompared with control eyes (Figure 4L). The IFN-
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at 6 hours after treatment, TLR9 mRNA expression was
elevated (1.4-fold) in the retinas of CpG-ODN–treated
eyes compared with controls and was further in-
creased (fourfold) at 24 hours (Figure 4M). In summary,
these data demonstrate that topical application of a
TLR9 ligand to the debrided corneal surface induces
infiltration of neutrophils and macrophages into the
retina, activation of resident microglia, and local pro-
duction of IFN-.
Intraocular Inflammation in Response to Corneal
CpG-ODN Is TLR9 Dependent
The infiltration of neutrophil and Iba-1 monocyte-de-
rived cells in the retina after topical exposure to CpG-
ODN was absent in TLR9/ mice (see Supplemental
Figure S1, A and B, at http://ajp.amjpathol.org). In
Figure 2. Inflammatory cell infiltrate and corneal haze in Mafia control
(nondimerized; no macrophage depletion) and Mafia-treated (dimerized;
macrophage depletion) mice 24 hours after corneal CpG-ODN. In vivo
epifluorescence image of a Mafia control mouse eye containing extensive
eGFP inflammatory macrophages in the central cornea (inset) and iris/
anterior chamber (A) compared with a Mafia-treated eye that has fewer
eGFP inflammatory cells (B). The dashed line demarcates the limbus (cor-
nea-scleral junction), and arrows outline the pupil margin of the underlying
iris. CpG-ODN increased corneal haze (C) in Mafia control corneas compared
with Mafia-treated corneas. An abrogated neutrophil response in Mafia-
treated corneas compared with Mafia control corneas 24 hours after CpG-
ODN treatment is shown (D). CpG-ODN induced neutrophil and macro-
phage infiltration into the corneas of bone marrow chimeric mice (E and F)
(n  3 to 6 mice per group). Data are given as mean  SEM. ns, not
significant. *P  0.05, **P  0.01, and ***P  0.001.dimerizer-treated Mafia mice, there was no retinal inflam-mation, providing strong evidence for the role of c-fms–
expressing myeloid cells in TLR9-dependent responses
in the posterior portion of the eye after corneal exposure
to CpG-ODN.
Acute Retinal Inflammation in Response to
Corneal CpG-ODN Is Selective for TLR9
Ligands and Does Not Occur after Exposure to
TLR4 Ligand, LPS
Although there have been extensive studies of the effects
of the TLR4 ligand, LPS, on the eye after either direct
injection into the anterior chamber or vitreous36 (model-
ing infections within the eye) or systemic exposure37
(modeling anterior uveitis that often accompanies sys-
temic exposure to LPS), to our knowledge, there have
been no reports of retinal inflammation as a sequel to
the topical application of TLR4 ligands to the surface of
the eye (mimicking models of keratitis). Thus, we
treated mice topically with 20 g of LPS in an identical
manner to CpG-ODN and as previously reported.10,21
These experiments revealed no evidence of vitritis or
retinal inflammation (see Supplemental Figure S1 at
http://ajp.amjpathol.org).
Acute Retinal Inflammation Does Not Occur
after Systemic Exposure to CpG-ODN
To examine the possibility that CpG-ODN may be medi-
ating the observed effect on the retina, secondary to its
absorption via the nasolacrimal system or conjunctival
lymphatics, we performed a further experiment in which a
group of animals were given a single i.p. or i.v. injection
of 40 g of CpG-ODN and the cornea of one eye was
debrided to mimic a local injury. No corneal or retinal
inflammation was noted in this experiment (see Supple-
mental Figure S1C at http://ajp.amjpathol.org). To deter-
mine whether CpG-ODN–induced intraocular inflamma-
tion could cause an inflammatory response in the
untreated contralateral eye, animals received 20 g of
CpG-ODN in the right eye and either debridement only
(to mimic injury) or no treatment in the left eye. No inflam-
mation was observed in the retina of the left eye in either
experiment (see Supplemental Figure S1, D and E, at
http://ajp.amjpathol.org), confirming that retinal inflamma-
tion was localized to the eye topically exposed to CpG-
ODN. In summary, systemic exposure to 40 g of CpG-
ODN failed to elicit an acute intraocular response, even in
the presence of corneal injury.
Retinal Inflammation Follows Subconjunctival
Injection of CpG-ODN
To determine whether the response previously described
is specific to corneal application or whether CpG-ODN
can access the retina and vitreous from other extrabulbar
routes to cause retinal inflammation, 20 g of CpG-ODN
or control ODN was injected into the subconjunctival
space. Retinas were examined at 24 hours for evidence
filtrates
ye (I). S
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displayed no signs of inflammatory cell infiltration (see
Supplemental Figure S2A at http://ajp.amjpathol.org). In
CpG-ODN–injected eyes, infiltrating IB4Iba-1CD68
macrophages and NIMP neutrophils were observed in
the retina (see Supplemental Figure S2, B and C, at
http://ajp.amjpathol.org), thus confirming that CpG-ODN
injected subconjunctivally can result in inflammation in
the posterior compartment of the mouse eye.
CpG-ODN Applied to the Debrided Corneal
Surface Quickly Reaches the Retina
We hypothesized that the retinal inflammation observed
secondary to topical application of CpG-ODN was the
result of diffusion of this small–mol. wt. molecule through
the corneal stroma, aqueous humor, and vitreous humor to
reach the posterior segment of the eye, where it directly
Figure 3. Evidence of widespread intraocular inflammation 24 hours afte
infiltration (red) in the limbus and anterior segment of control ODN and LPS-t
in the anterior chamber, iris, and ciliary body (CB). In vivo scanning l
demonstrating clear retinal vasculature (D and E) compared with the hazy
coherence tomography image demonstrating the presence of inflammatory in
with normal appearance of the central retina from a control ODN-treated eactivates retinal myeloid-derived cells. To test this notion,we tracked the fate of FITC-labeled CpG-ODN (mol. wt., 6.6
kDa) applied to the debrided cornea. The results of a fun-
dus examination at 24 hours were normal in naïve contralat-
eral eyes, and no fluorescence was detected (Figure 5, A
and B). In FITC CpG-ODN–treated eyes, retinal vessels
were also normal (Figure 5C); however, a fluorescent signal
was present throughout the posterior segment at 24 hours
(Figure 5D). At 1 week, fluorescence was still detectable in
FITC CpG-ODN–treated eyes compared with naïve con-
tralateral eyes (data not shown).
Cryosections of FITC CpG-ODN–treated eyes at 24
hours revealed a gradient in fluorescence, indicative of
diffusion from the cornea, through to the posterior seg-
ment (Figure 5E). No fluorescence signal was detected in
corneal whole mounts of either naïve or debrided con-
tralateral eyes (Figure 5F) compared with intense green
signal in the FITC CpG-ODN–treated corneas (Figure
5G). Confocal analysis revealed FITC CpG-ODN in the
l application of CpG-ODN to the debrided cornea. Moderate neutrophil
yes (A and B). In CpG-ODN–treated eyes (C), many neutrophils were present
hthalmoscopy and fluorescein angiography of control ODN-treated eyes
nce of the fundus from CpG-ODN–treated eyes (F and G). In vivo optical
(arrows) in the vitreous/retina of the CpG-ODN–treated eye (H) compared
cale bar  200 m (I).r topica
reated e
aser op
appearaextracellular space and within keratocytes, macrophages,
at 24 ho
216 Chinnery et al
AJP January 2012, Vol. 180, No. 1and DCs in the cornea, with occasional uptake by epi-
thelial cells also noted. Microscopy of retinal whole
mounts at 4 hours revealed a lack of FITC signal in the
contralateral retina (Figure 5H) compared with obvious
fluorescence in the ganglion cell layer of the retina 4
hours after FITC CpG-ODN treatment (Figure 5I). Naïve
retinal whole mounts at 24 hours failed to demonstrate
Figure 4. Characterization of retinal inflammation after topical applicat
already present in the retina 6 hours after CpG-ODN treatment (A, arrowh
of the time course of neutrophil infiltration on retinal whole mounts
characteristics in retinas from control ODN-treated eyes at 24 hours (D: low
cells (E) are normal vitreous hyalocytes. After CpG-ODN treatment, nume
the altered morphological characteristics of Iba-1 microglia (H, asterisk
after corneal CpG-ODN, large Iba-1 microglia with stout processes (I)
perivascular MHC class II DCs in the control retina (J) can be compare
corneal CpG-ODN treatment (K). The density of MHC class II cells in reti
RT-PCR revealed a significant fold increase (compared with control OD
increasing by 24 hours, whereas IFN- up-regulation was only apparent
bars are as shown. *P  0.05, **P  0.01, and ***P  0.001.colocalization of FITC CpG-ODN (Figure 5J) and CD68cells (Figure 5, K and L), contrasting with the obvious
uptake of labeled CpG-ODN by large round Iba-1 IB4
macrophages and occasional microglia in the inner retina
of CpG-ODN–treated animals, where the signal colocal-
ized with CD68 endosomal compartments of these cells
(Figure 5, M–O; see also Supplemental Figure S3, D–F, at
http://ajp.amjpathol.org). Additional CpG-FITC localiza-
pG-ODN onto the debrided cornea. Adherent intravascular neutrophils
Many extravascular neutrophils are evident by 24 hours (B). Quantitation
a peak at 24 hours (C). Healthy, ramified, microglial morphological
r; E: higher magnification) or 1 week (F). The fewer bright red dendriform
a-1 inflammatory macrophages (G–I) were observed in the retina. Note
side rounded Iba-1 activated macrophages (H, arrowheads). At 1 week
rly evident, compared with microglia in control retinas (F). Typical rare
the increased number of MHC class II cells in the retina 24 hours after
le mounts from control ODN or CpG-ODN–treated corneas (L). Real-time
d corneas) in TLR9 mRNA in the retina as early as 6 hours (M), further
urs (n  5 to 10 mice per group). Data are given as mean  SEM. Scaleion of C
eads).
revealed
powe
rous Ib
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N-treatetion studies, performed in TLR9/ mice, confirm the
CpG-ODN-Induced Intraocular Inflammation 217
AJP January 2012, Vol. 180, No. 1presence of CpG-FITC in the retina 24 hours after topical
application; however, there were no infiltrating inflamma-
tory cells present (see Supplemental Figure S3, A–C, at
http://ajp.amjpathol.org).
Discussion
In light of the global burden of vision-threatening keratitis
secondary to bacterial, viral, fungal, and protozoan infec-
tions, the mechanisms of inflammation in the transparent
cornea have been extensively investigated.We have used a
sterile model of keratitis to investigate the role of macro-
phages and DCs in the induction of corneal inflammation
after application of TLR ligands.4,10,13,21,28 In this sterile
model and in infectious microbial keratitis, we21 and others
have previously demonstrated the presence and activation
of TLR9 in the mouse cornea and characterized the CXC
chemokines that recruit neutrophils and macrophages into
this avascular tissue.5,22,23 In the present study, we con-
firmed that CpG-ODN, a synthetic mimic of bacterial and
viral DNA, topically applied to the injured corneal epithelium
of WT, but not TLR9/, mice results in an acute neutro-philic and delayed macrophage/monocytic response in the
cornea. We also demonstrate, for the first time to our knowl-
edge, widespread intraocular inflammation involving the an-
terior uveal tract, vitreous, and retina. The amelioration of
the corneal and intraocular response in Mafia mice strongly
implicates a role for monocyte-derived macrophages in the
recognition of CpG-ODN, which accords with our previous
demonstration of such a mechanism for A. fumigatus kera-
titis29 and TLR4-mediated responses to LPS in the mouse
cornea.10 In addition, data from bone marrow chimeras, in
which Cx3cr1
gfp/ bone marrow was transplanted into le-
thally irradiated TLR9/ mice, support a role for resident
corneal monocyte-derived cells in the recruitment of neu-
trophils and macrophages to the cornea after topical appli-
cation of TLR9-specific CpG-ODN.
Based on their capacity to activate different subsets of
myeloid cells, synthetic TLR9 ligand homologues, un-
methylated CpG-ODNs, are classified as type A, B, or
C.16 Type A CpG-ODNs activate plasmacytoid DCs to
produce IFN-/, whereas type B CpG-ODNs are poor
inducers of IFN-/ but strongly activate B cells and
ure 5. Distribution of FITC-CpG-ODN in the mouse eye after topical
plication to the injured cornea. In vivo images of the mouse fundus in
LB/c mice (A–D), showing normal retinal vasculature in bright-field mode
and C). No detectable fluorescent signal (B) is evident in the naïve
ntralateral eye; however, a green signal is clearly evident in the FITC-CpG-
N–treated cornea at 24 hours (D). Cryosection of a C57BL/6 eye 24 hours
er FITC-CpG-ODN, showing an intense green signal in the cornea (E).
nfocal image of corneal whole mounts of a naïve contralateral eye (F) and
FITC-CpG-ODN–treated eye (G) at 4 hours. Confocal images of retinal
ole mounts from a naïve contralateral eye (H) and an FITC-CpG-ODN–
ated eye (I). CD68 FITC microglia in a naïve contralateral eye at 24
urs (J–L) compared with CD68 FITC macrophages (arrows) in the
ina of an FITC-CpG-ODN–treated eye (M–O).Fig
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tor- production.17 We found a lack of inflammation after
corneal exposure to type A CpG-ODN, which may reflect
the rarity of resident plasmacytoid DCs and natural killer
cells in the noninflamed mouse cornea.19 By comparison,
the response to type B CpG-ODN was predictable be-
cause macrophages are widely distributed throughout
the corneal stroma.7,9,18
The unexpected retinal inflammation that accompa-
nied exposure of the injured corneal surface to CpG-
ODN appears to be unique to TLR9 responses be-
cause previous studies have not described such
inflammatory changes after exposure to ultrapure LPS,
Pam3Cys, and poly(I:C) (TLR4, TLR2, and TLR3 li-
gands, respectively). In addition, we did not observe
posterior segment inflammation in the present investi-
gation after identical LPS treatment. There are several
possible explanations for the retinal inflammation that
accompanies corneal CpG-ODN treatment that are
worthy of consideration. First, cytokines and chemo-
kines produced in the cornea may diffuse to the ante-
rior uveal tract (iris and ciliary body) and the posterior
segment of the eye (vitreous and retina) and, thereby,
exert their effects. We believe this unlikely on the
grounds that TLR4 or TLR2 ligands induce a more
intense corneal neutrophilic infiltration and cause the
production of a similar cascade of cytokines and
chemokine signals,21,38 yet fail to cause posterior seg-
ment inflammation. A second mechanism considered
was secondary exposure to CpG-ODN via a systemic
route, perhaps as a consequence of the ligand enter-
ing the tears or limbal vasculature (the rich plexus of
vessels, including lymphatics, encircling the avascular
cornea) during debridement and topical application.
However, the lack of intraocular inflammation at 24
hours in naïve contralateral eyes, injury-only contralat-
eral eyes, or the eyes of animals that had received a
corneal injury in conjunction with an i.v. or i.p. injection
of CpG-ODN makes this pathway unlikely. It does not
preclude such a mechanism operating at higher doses
or during active systemic viral disease, both of which
are under investigation in our laboratories.
The detection of FITC-conjugated CpG-ODN in the
retina only hours after administration to the injured cor-
nea, and its localization within retinal macrophages led
us to propose that CpG-ODN, because of its small size
(approximately 6 kDa), readily diffuses through the cor-
nea and aqueous environment of the eye to directly ac-
tivate TLR9 myeloid cells in the retina. A similar transit
time of hours has been shown during transcorneal ionto-
phoresis of fluorescent ODN (21mer) in rats.39 These data
suggest a mechanism by which the unmethylated CpG-
ODN motifs released during bacterial or viral infections,
perhaps even secondary to bacteriolysis after antibiotic
therapy, may directly lead to activation of intraocular my-
eloid cells. Previous reports have demonstrated that corneal
inoculation with P. aeruginosa leads to up-regulation of IL-6
and KC mRNA in the retina,40 and during corneal HSV
infection, a few retinal cells in the outer nuclear layer ex-
press HSV antigen and undergo apoptosis.41 Both these
studies suggest that inoculation of the mouse cornea withHSV or P. aeruginosa results in minor retinal inflammatory
changes; however, the mechanism of these posterior seg-
ment changes was not investigated.
Evidence that brain microglia are activated by CpG-
ODN42,43 would make it extremely likely that retinal
microglia would recognize this TLR9 ligand. In a study
with parallels to our own, Deng et al44 noted that intra-
cisternal injection (homologous to direct injection into
the vitreous or anterior chamber) of CpG-ODN in mice
and rats caused meningitis, which could be abrogated
by macrophage depletion and anti-sense targeting of
NF-, that leads to down-regulation of pro-inflamma-
tory cytokine production.
The findings of the present study lead us to postulate
that activation of retinal microglia and other ocular
macrophage populations,45 secondary to corneal mi-
crobial infection, may have subtle effects on the pro-
gression of posterior segment diseases, including age-
related macular degeneration.46 Recent evidence47
has shown that, after co-culture with LPS-activated ret-
inal microglia, retinal pigment epithelial cells produced
the chemotactic factors chemokine ligand 2, chemo-
kine ligand 5, stromal-cell derived factor-1 and the
pro-angiogenic molecule vascular endothelial growth
factor. The latter growth factor has a direct role in the
wet neovascular form of age-related macular degener-
ation. Thus, we hypothesize that activation of retinal
microglia, occurring as secondary sequelae to innate
immune responses to viral and bacterial DNA at the
ocular surface, may have a previously unsuspected
role in the progression of retinal diseases.
Finally, data from this study demonstrating that corneal
CpG-ODN can cause TLR9-mediated inflammation in the
retina highlight the need for consideration of contaminat-
ing CpG motifs in antisense ODN or plasmids used in
ocular gene therapy. Specific depletion of unmethylated
CpG motifs from plasmid DNA has been shown in other
models to improve the safety of gene therapy treatments by
reducing unwanted inflammation.48 In addition, the rapid
dissemination of immunostimulatory ODN to the posterior
segment of the eye after application to a compromised
corneal epithelium or via subconjunctival injection could
offer promise of a novel mode of therapeutic delivery to treat
intraocular inflammation using inhibitory ODN.49
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